Study for cluster headaches and trigeminal nerve pain
Part of Brain & nervous system, Mouth & dental clinical trials.
This study looks at people with certain severe headache disorders (cluster-type headaches or SUNCT/SUNA) or trigeminal neuralgia (sharp facial nerve pain). Researchers want to better understand these conditions and see how study testing/record review may help care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with a specific headache condition like cluster headache, SUNCT, SUNA, hemicrania continua, or trigeminal neuralgia
- You are 18 years or older (for healthy volunteer participation)
- You can sign permission for the study team to access your medical records and imaging
- You can give informed consent (or a legally authorized representative can)
- You do not have a health situation expected to limit life to under 1 year
- No active drug or alcohol problems that would make it hard to follow study steps
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at measurable “pain signals” (biomarkers) in people with certain headache disorders or lumbar nerve pain, and compares them with healthy people. It may help researchers better understand what drives pain and how it can be detected.
This study is designed to learn more about a group of rare headache disorders called trigeminal autonomic cephalalgias (TACs). If you have one of these conditions, participating could help doctors better understand how they behave over time and improve care for others like you.
This study measures nerve activity (electrical signals in nerves) in people who have trigeminal neuralgia and are getting a common facial pain procedure. It may help researchers better understand the condition and improve future treatments.
This trial tests a procedure that uses targeted pulses of energy and a special blood-platelet solution to calm a specific nerve cluster at the back of the nose, which may reduce the frequency and intensity of cluster headache attacks. It is for people whose headaches have not improved enough with standard preventive medicines.
This trial tests whether injections of botulinum toxin type A can reduce frequent, severe cluster headache attacks by targeting a facial nerve area. It’s for people whose cluster headaches have not responded well—or have caused side effects—to standard preventive treatments.
This study looks at how emotions and memory are affected in people with chronic trigeminal neuralgia (a type of facial nerve pain). Participants will have an MRI scan and fill out questionnaires to help researchers understand the link between chronic pain and cognitive changes.
Hear when a new Cluster Headache trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.